Active/Completed Active GrantsCompleted Grants PI Name Sort descending PI Organization Title Grant Number Program Official Whitman, Eric Atlantic Health System, Inc. United States The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC Corp) 3UG1CA239772-06S1 Vanessa A. White, M.P.H. Whitman, Eric Atlantic Health System, Inc. United States The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC Corp) 3UG1CA239772-06S1 Vanessa A. White, M.P.H. Winger, Joseph Giles Duke University United States Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer 5R01CA291768-02 Brennan Streck, Ph.D., RN, M.P.H. Winger, Joseph Giles Duke University United States Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer 5R01CA291768-02 Brennan Streck, Ph.D., RN, M.P.H. Winger, Joseph Giles Duke University United States Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer 5R01CA291768-02 Brennan Streck, Ph.D., RN, M.P.H. Winters-Stone, Kerri M Oregon Health & Science University United States Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer 5R01CA248059-05 Goli Samimi, Ph.D., M.P.H. Winters-Stone, Kerri M Oregon Health & Science University United States Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer 5R01CA248059-05 Goli Samimi, Ph.D., M.P.H. Wright, Alexi A Dana-Farber Cancer Inst United States Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among adults with advanced ovarian cancer on PARP inhibitors 5R01CA289547-02 Goli Samimi, Ph.D., M.P.H. Wright, Alexi A Dana-Farber Cancer Inst United States Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among adults with advanced ovarian cancer on PARP inhibitors 5R01CA289547-02 Goli Samimi, Ph.D., M.P.H. Xu, Xiangxi Mike University Of Miami School Of Medicine United States Countering microtubule stabilization within hair follicles in ovarian cancer chemotherapy 5R01CA286527-02 Rachel Altshuler, Ph.D. Xu, Xiangxi Mike University Of Miami School Of Medicine United States Countering microtubule stabilization within hair follicles in ovarian cancer chemotherapy 5R01CA286527-02 Rachel Altshuler, Ph.D. Xu, Chunhui Emory University United States High-throughput assessment of chemotherapy-induced cardiotoxicity in 3D human cardiomyocytes 1R21CA285254-01A1 Eileen Dimond, R.N., M.S. Xu, Chunhui Emory University United States High-throughput assessment of chemotherapy-induced cardiotoxicity in 3D human cardiomyocytes 1R21CA285254-01A1 Eileen Dimond, R.N., M.S. Yang, Qing University Of Texas Med Br Galveston United States The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy 5R01CA273001-02 Rachel Altshuler, Ph.D. Yang, Qing University Of Texas Med Br Galveston United States The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy 5R01CA273001-02 Rachel Altshuler, Ph.D. Pagination « First First page ‹ Previous Previous page … 24 25 26 27 Next › Next page Last » Last page